Anterior chamber cosmetic iris implants permanently alter the apparent iris color. Previous reports of these implants highlight adverse outcomes with severe ocular morbidity, including glaucoma, corneal endothelial decompensation, iris damage, and uveitis, which may result in vision loss.1-3 These reports concern the NewColorIris implant (Kahn Medical Devices). We report a case involving a new cosmetic iris implant, BrightOcular (Stellar Devices LLC), causing iris damage, uveitis, and corneal endothelial damage.
Kelly A, Kaufman SC. Corneal Endothelial Cell Loss and Iritis Associated With a New Cosmetic Iris Implant. JAMA Ophthalmol. 2015;133(6):723–724. doi:10.1001/jamaophthalmol.2015.0488
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: